Rafferty Asset Management, LLC
Position in SNDX — Syndax Pharmaceuticals Inc
CIK 1389426
New York, NY
Position in SNDX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,137,623
-$775,906 QoQ
Shares Held
97,787
-21.6% QoQ
Ownership
0.110%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#96
of 242 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SNDX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Rafferty Asset Management, LLC holds $331,711,589 across 163 Biotechnology names. SNDX ranks #56 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
65,798 | $32,683,840 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
38,534 | $24,027,490 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
55,332 | $16,656,591 | |
| 4 | MRNA |
Moderna, Inc.
|
111,906 | $7,836,777 | |
| 5 | INCY |
Incyte Corp
|
44,663 | $5,062,997 | |
| 6 | APGE |
Apogee Therapeutics, Inc.
|
33,369 | $4,429,067 | |
| 7 | ORKA |
Oruka Therapeutics, Inc.
|
43,110 | $4,102,778 | |
| 8 | KYMR |
Kymera Therapeutics, Inc.
|
35,287 | $4,046,360 |
All Filings in SNDX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,137,623 | 97,787 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,913,529 | 124,723 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,402,422 | 161,943 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,181,931 | 141,822 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,180,411 | 126,045 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,107,381 | 171,541 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $2,355,341 | 178,165 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,301,798 | 171,522 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $3,652,697 | 177,920 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $8,883,064 | 373,238 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $8,717,063 | 403,381 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $4,125,480 | 284,124 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $7,018,812 | 335,347 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $5,974,488 | 282,883 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $6,738,192 | 264,762 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $3,517,559 | 146,382 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,498,872 | 77,904 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,267,725 | 130,479 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $3,454,942 | 157,832 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $1,409,018 | 73,732 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $2,372,413 | 138,172 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $3,252,060 | 145,441 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $396,383 | 17,823 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $389,604 | 26,396 | Shares | Sole | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||